PLEASE NOTE: All yellow fields are to help you fill in this template. Please make sure you fill in all relevant information, no yellow areas remain in the final agreement and remove this information box. For all cross border services please provide the completed “International HCP Engagement Request Form” to the Legal Department. This Agreement may only be signed after local approval of all affected countries to ensure adherence to local laws and codes. Ensure this Agreement is signed by two authorized persons from RDAP. SPEAKER SERVICES AGREEMENT between Customer name Title Name of laboratory – hereinafter referred to as (“Customer name”)– and Roche Diagnostics NZ Ltd 15 Rakino Way Mt Wellington 1060 PO Box 62089, Sylvia Park 1644 Auckland New Zealand – Hereinafter referred to as “ROCHE” – Speaker Services Agreement 1/5 1. scope of the Speaker Services 1.1 Customer name has special expertise in the field of ………………………….. Customer name shall render to ROCHE speaker services regarding ……………………….. The speaker services shall include the following: a) Customer name will give a speech/ppt concerning “Title of Presentation” on (date & month) at the Roche User Group Meeting, Taupo, New Zealand b) Customer name will provide ROCHE for ROCHE’s free and unrestricted future use with a PowerPoint presentation of the speech and any presentation used during the speech, which will be handed over to ROCHE as a .pdf or .ppt file by date…… at the latest 1.2 The manager of the dept. of Customer name has been properly informed about the carrying out of these speaker services by Gane and has approved them. 1.3 Any speaker services under this Agreement are rendered independently from any possible sale and purchase agreements between ROCHE and Customer name’s employer. Nothing herein shall be an inducement for Customer name or his employer to recommend, prescribe, purchase, supply, sell or administer a particular product of ROCHE. Customer name herewith confirms that the subject matter of the Agreement and any consideration and compensation is in compliance with applicable laws and standards, that all required approvals by Customer name’s employer, if any, are obtained and that there is no conflict of interest which would prevent Customer name from entering into this Agreement. 1.4 Customer name shall perform the speaker services under this Agreement in person as an independent consultant without becoming an employee of ROCHE. 1.5 Contact person within ROCHE is: Lara Hashimoto (lara.hashimoto@roche.com ) 2. REMUNERATION 2.1 For the speaker services conducted by Customer name hereunder, ROCHE shall pay (NZD xxx) honorarium as a fixed price. 2.2 Travel expenses of Customer name require the prior written consent of ROCHE (list if applicable) Any other expenses in connection with or during the event shall be Customer name’s responsibility unless and to the extent ROCHE expressly agreed in advance in writing to reimburse such expenses and only if ROCHE is provided with original receipts for such expenses. 2.3 The remuneration will be paid after services are rendered by Customer name and within thirty (30) days after receipt of an appropriate invoice to the following bank account: Customer name shall refer in the invoice to the purchase order number contained in the purchase order of ROCHE. Speaker Services Agreement 2/5 2.4 It is the Parties’ common understanding that Customer name shall be responsible for any taxes on any payment or benefit in kind received under this Agreement including without limitation any necessary declarations. 3. CONFIDENTIALITY AND PUBLICATIONS 3.1 Customer name shall not publish and hold in strict confidence any information, data, documentation and materials either received from ROCHE or created under this Agreement (“Confidential Information”) without the prior written consent of ROCHE. 3.2 Exempted from such obligation shall be Information which Customer name can prove a) was fully in Customer name’s possession prior to receipt from ROCHE; or has been independently developed as shown by respective documents; or b) was in the public domain at the time of receipt from ROCHE; or c) was lawfully received from some third party having a right of further disclosure; or d) is required to be disclosed by law or applicable government regulations. 3.3 As the Roche Group adheres to a multitude of global, regional and local codes of conduct and best industry practices and standards, the Roche Group is collecting data of any arrangements similar to this Agreement in an internal register and reserves its right to disclose information regarding the subject matter of this Agreement including any consideration and compensation, including the amount or value, the recipient, the purpose and the date of the support, where and when ROCHE deems appropriate. 4. TERM 4.1 This Agreement shall come into force after signature of both parties. 4.2 Any obligations regarding confidentiality, transfer of intellectual property or publication shall be effective for ten (10) years after the effective date. 5. MISCELLANEOUS 5.1 If any provision of this Agreement is or becomes invalid or unenforceable, the validity of the remainder of this Agreement shall not be affected thereby. 5.2 The termination, any changes or amendments including the waiver of any provisions are effective only if made in writing. The waiving of the requirement for the written form must likewise satisfy such form. 5.3 Customer name may not transfer or assign this Agreement in whole or in part to a third party without the prior written consent of ROCHE. 5.4 ROCHE is entitled to assign this Agreement on whole or in part as well as rights and obligations under this Agreement to its Affiliates. Affiliate means (i) an organization, which directly or indirectly controls ROCHE, (ii) an organization, which is directly or indirectly controlled by ROCHE, (iii) an organization, which is controlled, directly or indirectly, by the ultimate parent company of ROCHE. Control as per (i) to (iii) is Speaker Services Agreement 3/5 defined as owning fifty percent or more of the voting stock of a company or having otherwise the power to govern the financial and the operating policies or to appoint the management of an organization. For the purpose of this Agreement, Chugai Pharmaceutical Co., Ltd, 1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo, 103-8324, Japan ("Chugai"), shall not be deemed an Affiliate of ROCHE, unless ROCHE opts for an inclusion of Chugai, by giving written notice to the other party. 5.5 This Agreement shall be governed and construed in accordance with the laws of New Zealand. The parties agree to the exclusive jurisdiction of the competent courts in Zealand. IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly authorized officers on the following date. ………………………….. New Zealand, (Date) Roche Diagnostics NZ Ltd _______________________________ Lara Hashimoto General Manager Roche Diagnostics New Zealand Ltd _____________________________ Customer’s name Customer title Name of laboratory _________________________________ Arvin Sharma Compliance Officer & Finance Manager Roche Diagnostics New Zealand Ltd Speaker Services Agreement 4/5 Speaker Services Agreement 5/5